Native PLGA nanoparticles attenuate Aβ-seed induced tau aggregation under in vitro conditions: potential implication in Alzheimer’s disease pathology

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Native PLGA nanoparticles attenuate Aβ-seed induced tau aggregation under in vitro conditions: potential implication in Alzheimer’s disease pathology ; volume:14 ; number:1 ; day:2 ; month:1 ; year:2024 ; pages:1-16 ; date:12.2024
Scientific reports ; 14, Heft 1 (2.1.2024), 1-16, 12.2024

Creator: Paul, Pallabi Sil
Patel, Tark
Cho, Jae-Young
Yarahmady, Allan
Khalili, Aria
Semenchenko, Valentyna
Wille, Holger
Kulka, Marianna
Mok, Sue-Ann
Kar, Satyabrata

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-023-50465-x

URN: urn:nbn:de:101:1-2024031508332949495058

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:47 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Paul, Pallabi Sil
Patel, Tark
Cho, Jae-Young
Yarahmady, Allan
Khalili, Aria
Semenchenko, Valentyna
Wille, Holger
Kulka, Marianna
Mok, Sue-Ann
Kar, Satyabrata
SpringerLink (Online service)

Other Objects (12)

Unconjugated PLGA nanoparticles attenuate temperature-dependent β-amyloid aggregation and protect neurons against toxicity: implications for Alzheimer’s disease pathology

β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology

The Lipoxygenases: Their Regulation and Implication in Alzheimer’s Disease

Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of Alzheimer’s disease

Correction: Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of Alzheimer’s disease

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization

SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation

Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice

Monitoring Alzheimer Amyloid Peptide Aggregation by EPR

C3N nanodots inhibits Aβ peptides aggregation pathogenic path in Alzheimer’s disease

De novo aggregation of Alzheimer’s Aβ25-35 peptides in a lipid bilayer

Unconjugated PLGA nanoparticles attenuate temperature-dependent β-amyloid aggregation and protect neurons against toxicity: implications for Alzheimer’s disease pathology

β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology

The Lipoxygenases: Their Regulation and Implication in Alzheimer’s Disease

Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of Alzheimer’s disease

Correction: Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of Alzheimer’s disease

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization

SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation

Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice

Monitoring Alzheimer Amyloid Peptide Aggregation by EPR

C3N nanodots inhibits Aβ peptides aggregation pathogenic path in Alzheimer’s disease

De novo aggregation of Alzheimer’s Aβ25-35 peptides in a lipid bilayer

Unconjugated PLGA nanoparticles attenuate temperature-dependent β-amyloid aggregation and protect neurons against toxicity: implications for Alzheimer’s disease pathology

β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology

The Lipoxygenases: Their Regulation and Implication in Alzheimer’s Disease

Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of Alzheimer’s disease

Correction: Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of Alzheimer’s disease

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization

SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation

Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice

Monitoring Alzheimer Amyloid Peptide Aggregation by EPR

C3N nanodots inhibits Aβ peptides aggregation pathogenic path in Alzheimer’s disease

De novo aggregation of Alzheimer’s Aβ25-35 peptides in a lipid bilayer

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Native PLGA nanoparticles attenuate Aβ-seed induced tau aggregation under in vitro conditions: potential implication in Alzheimer’s disease pathology

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Unconjugated PLGA nanoparticles attenuate temperature-dependent β-amyloid aggregation and protect neurons against toxicity: implications for Alzheimer’s disease pathology

β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology

The Lipoxygenases: Their Regulation and Implication in Alzheimer’s Disease

Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of Alzheimer’s disease

Correction: Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of Alzheimer’s disease

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization

SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation

Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice

Monitoring Alzheimer Amyloid Peptide Aggregation by EPR

Monitoring Alzheimer Amyloid Peptide Aggregation by EPR

C3N nanodots inhibits Aβ peptides aggregation pathogenic path in Alzheimer’s disease

De novo aggregation of Alzheimer’s Aβ25-35 peptides in a lipid bilayer

Unconjugated PLGA nanoparticles attenuate temperature-dependent β-amyloid aggregation and protect neurons against toxicity: implications for Alzheimer’s disease pathology

β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology

The Lipoxygenases: Their Regulation and Implication in Alzheimer’s Disease

Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of Alzheimer’s disease

Correction: Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of Alzheimer’s disease

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization

SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation

Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice

Monitoring Alzheimer Amyloid Peptide Aggregation by EPR

Monitoring Alzheimer Amyloid Peptide Aggregation by EPR

C3N nanodots inhibits Aβ peptides aggregation pathogenic path in Alzheimer’s disease

De novo aggregation of Alzheimer’s Aβ25-35 peptides in a lipid bilayer

Unconjugated PLGA nanoparticles attenuate temperature-dependent β-amyloid aggregation and protect neurons against toxicity: implications for Alzheimer’s disease pathology

β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology

The Lipoxygenases: Their Regulation and Implication in Alzheimer’s Disease

Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of Alzheimer’s disease

Correction: Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of Alzheimer’s disease

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization

SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation

Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice

Monitoring Alzheimer Amyloid Peptide Aggregation by EPR

Monitoring Alzheimer Amyloid Peptide Aggregation by EPR

C3N nanodots inhibits Aβ peptides aggregation pathogenic path in Alzheimer’s disease

De novo aggregation of Alzheimer’s Aβ25-35 peptides in a lipid bilayer

Related objects

Reset password